1-13 of 13
Ying Zhu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Retrospective Comparison of Allogenic and Autologous Hematopoietic Stem Cell Transplantation in Patients with T-Cell Lymphoblastic Lymphoma

Ying Zhu, Tao You, Sicheng Ai, Mao Jin, Mengya Cong, Depei Wu, Haiwen Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 7112.
https://doi.org/10.1182/blood-2023-185966
Published: 2023
Journal Articles

The Impact of Chimeric Antigen Receptor T Cell Quality to Clinical Safety and Efficacy in Non-Hodgkin Lymphomas

Qian Wang, Liqing Kang, Yishan Duan, Mao Jin, Ying Zhu, Mengya Cong, Xin Xiang, Xiao Ma, Lei Yu, Depei Wu, Haiwen Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 6676–6677.
https://doi.org/10.1182/blood-2022-165184
Published: 2022
Journal Articles

Phase 1 Dose Escalation and Cohort Expansion Study of the Anti-ROR1 Antibody-Drug Conjugate Zilovertamab Vedotin (MK-2140) for the Treatment of Non-Hodgkin Lymphoma

Michael Wang, Matthew Mei, Paul M. Barr, Jacqueline Barrientos, Sven de Vos, Richard Furman, Krish Patel, Philip A. Thompson, Michael Choi, Avyakta Kallam, Ying Zhu, Samhita Chakraborty, Patricia Marinello, Stephen E. Spurgeon
Journal: Blood
Blood (2021) 138 (Supplement 1): 528.
https://doi.org/10.1182/blood-2021-148607
Published: 2021
Journal Articles

Myeloma Cell Associated Therapeutic Protein Discovery Using Single Cell RNA-Seq Data

Lijun Yao, MS, Reyka G Jayasinghe, PhD, Tianjiao Wang, BA, Julie O'Neal, PhD, Ruiyang Liu, BS, Michael P. Rettig, PhD, Chia-Feng Tsai, PhD, Steven M. Foltz, BS, MS, Danny Kohnen, MBA, Smrithi Mani, BS, Fernanda Martins Rodrigues, MSc, Michael C. Wendl, D SC, MS, PHS, Matthew A. Wyczalkowski, PhD, Scott R. Goldsmith, MD, Ying Zhu, PhD, Mark A Fiala, MSW, Liu Tao, BS, PhD, Ravi Vij, MD MBA, Li Ding, PhD, John F. DiPersio, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-142205
Published: 2020
Journal Articles

Single-Cell Transcriptomic and Proteomic Diversity in Multiple Myeloma

Reyka G Jayasinghe, PhD, Yige Wu, BS, Ying Zhu, PhD, Ruiyang Liu, BS, Mark A. Fiala, BS, Daniel R. Kohnen, MBA, Chia-Feng Tsai, PhD, Smrithi Mani, BS, Justin King, BS, Michael P. Rettig, PhD, Julie O'Neal, PhD, Tianjiao Wang, BA, Steven M. Foltz, BS, MS, Lijun Yao, MS, Hua Sun, PhD, Catrina Fronick, BS, Scott R. Goldsmith, MD, John F. DiPersio, MD PhD, Ravi Vij, MBBS, Liu Tao, BS, PhD, Li Ding, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5531.
https://doi.org/10.1182/blood-2019-131005
Published: 2019
Journal Articles

Long-Acting, Oxidation-Resistant IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Wild-Type IL-33, G-CSF or AMD3100

Carsten Alt, PhD, Faye Wu, Basha Stankovich, PhD, Joy Calaoagan, Sandra Schopies, Josephine Wu, Perry Liu, Billy Wong, Katalin Kauser, MD PhD, Peter Bringmann, PhD, JUN Shen, MD, Doug Schneider, Ying Zhu, MD, Thomas Thompson, Shaun M. Lippow, PhD, Shujun Yuan, PhD, Maxine Bauzon
Journal: Blood
Blood (2017) 130 (Supplement 1): 3202.
https://doi.org/10.1182/blood.V130.Suppl_1.3202.3202
Published: 2017
Journal Articles

Pembrolizumab in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Long-Term Efficacy from the Phase 1b Keynote-013 Study

Philippe Armand, MD PhD, Margaret A. Shipp, MD, Vincent Ribrag, MD, Jean-Marie Michot, MD, Pier Luigi Zinzani, MD PhD, John Kuruvilla, MD, Ying Zhu, PhD, Alejandro Daniel Ricart, MD, Arun Balakumaran, MD PhD SM, Craig H. Moskowitz, MD
Journal: Blood
Blood (2016) 128 (22): 1108.
https://doi.org/10.1182/blood.V128.22.1108.1108
Published: 2016
Journal Articles

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Xiao-Yan Zhao, PhD, Subramanian Yegneswaran, PhD, Maxine Bauzon, Derek Sim, Chandra Patel, PhD, Doug Schneider, Kirk McLean, Ying Zhu, MD, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu, PhD, Inge Ivens, PhD, Jun Xu, PhD, Peter Wolfgang Bringmann, PhD, Katalin Kauser, Charles Esmon, PhD
Journal: Blood
Blood (2016) 128 (22): 80.
https://doi.org/10.1182/blood.V128.22.80.80
Published: 2016
Journal Articles

Predicting FIX Activity in Prophylaxis Patients Using Recombinant FIX Fc Fusion Protein for Treatment of Bleeding Episodes

Jerry S Powell, MD, Margareth Ozelo, MD PhD, Margaret V. Ragni, MD MPH, John Pasi, MBChB, PhD FRCP, FRCPath, David J. Perry, MD PhD FRCP, FRCPath, Ying Zhu, MPH, Baisong Mei, MD PhD, Glenn F Pierce, MD PhD, Lian Li, PhD, Brian Robinson, MD
Journal: Blood
Blood (2014) 124 (21): 2842.
https://doi.org/10.1182/blood.V124.21.2842.2842
Published: 2014
Journal Articles

Molecular and Genetic Characterization of Fit, Elderly Patients Receiving Oral Fludarabine, Oral Cyclophosphamide and Intravenous Rituximab (OFOCIR) As Initial Treatment of Chronic Lymphocytic Leukemia (CLL)

Xavier C Badoux, MB BS, Giles Best, BSc (Hons), PhD, Sara Gabrielli, Miss, Melanie Hayes, PhD, Ying Zhu, PhD, Stephen Mulligan, MBBS, MD FRACP, FRCPA, Bryone J Kuss, MBBS, PhD FRCPA, FRACP
Journal: Blood
Blood (2014) 124 (21): 1959.
https://doi.org/10.1182/blood.V124.21.1959.1959
Published: 2014
Journal Articles

Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes

Doris V. Quon, MD PhD, Johnny N. Mahlangu, MBBCh, MMed, FCPath, Amy D Shapiro, John Pasi, MBChB, PhD FRCP, FRCPath, Ying Zhu, MPH, Glenn F Pierce, MD PhD, Lian Li, PhD, Geoffrey Allen, MD
Journal: Blood
Blood (2014) 124 (21): 1522.
https://doi.org/10.1182/blood.V124.21.1522.1522
Published: 2014
Journal Articles

Genomic Profiling In Fit, Elderly Patients Receiving Oral Fludarabine, Oral Cyclophosphamide and Intravenous Rituximab (ALLG CLL5 OFOCIR trial) As Initial Treatment Of Chronic Lymphocytic Leukemia (CLL)

XAVIER BADOUX, MBBS FRACP FRCPA, Giles Best, BSc (Hons) Ph.D., Sara Gabrielli, Miss, Ying Zhu, PhD, Melanie Hayes, PhD, Bryone J Kuss, MBBS, PhD, FRCPA, William Stevenson, MBBS, PhD, Stephen P Mulligan, MBBS, PhD, FRACP, FRCPA
Journal: Blood
Blood (2013) 122 (21): 1624.
https://doi.org/10.1182/blood.V122.21.1624.1624
Published: 2013
Journal Articles

Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators

Wu-Guo Deng, Ying Zhu, Kenneth K. Wu
Journal: Blood
Blood (2004) 103 (6): 2135–2142.
https://doi.org/10.1182/blood-2003-09-3131
Published: 2004